Literature DB >> 7392665

Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

C Clark, M I Foreman, K A Kane, F M McDonald, J R Parratt.   

Abstract

Coronary artery ligation in anesthetized rats was assessed as a method for the production of experimental dysrhythmias and for the determination of infarct size. Following occlusion of the left main coronary artery, very marked ventricular dysrhythmias occurred in two distinct phases, an early and a late phase, at 0-30 minutes and at 1 1/2--4 hours after ligation respectively. Infarct size was measured at 4 hours after ligation using nitroblue tetrazolium to stain for the depletion of two cytoplasmic enzymes, lactate dehydrogenase and NADPH diaphorase. In this model, lignocaine (10 mg/kg plus an infusion of 5 mg/kg/hr) and ORG 6001 (10 mg/kg plus an infusion of 2.5 mg/kg/hr) had marked antidysrhythmic activity but neither drug influenced infarct size. The model, because of its simplicity, reproducibility, and low cost, should be useful for the screening of potential antidysrhythmic agents and may also be used to determine infarct size following coronary artery ligation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7392665     DOI: 10.1016/0160-5402(80)90077-7

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  66 in total

1.  Unravelling mechanisms underlying ischaemic arrhythmias - the importance of models.

Authors:  L J Guppy; M J A Walker
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Differential action of two prolactin isoforms on ischemia and re-perfusion-induced arrhythmias in rats in vivo.

Authors:  T F Krzeminski; K Mitrega; M Porc; M Zorniak; F Ryszka; Z Ostrowska; B Kos-Kudła
Journal:  J Endocrinol Invest       Date:  2010-10-04       Impact factor: 4.256

3.  Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade.

Authors:  K L Philp; M Hussain; N F Byrne; M J Diver; G Hart; S J Coker
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

4.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

5.  Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.

Authors:  Hugh Clements-Jewery; Gajen Sunthar Kanaganayagam; Ruchi Kabra; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  Effects of a combination of metoprolol and dazmegrel on myocardial infarct size in rats.

Authors:  G R Bullock; I Leprán; J R Parratt; L Szekeres; C L Wainwright
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

7.  The role of catecholamines in the production of ischaemia-induced ventricular arrhythmias in the rat in vivo and in vitro.

Authors:  A Daugherty; K N Frayn; W S Redfern; B Woodward
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

8.  The effects of the combined administration of beta-adrenoceptor antagonists and non-steroidal anti-inflammatory drugs on ligation-induced arrhythmias in rats.

Authors:  O Fagbemi
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

9.  Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.

Authors:  H Dong; J Z Sheng; C M Lee; T M Wong
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

10.  The effects of ablations in the central nervous system on arrhythmias induced by coronary occlusion in the rat.

Authors:  M J Curtis; B A Macleod; M J Walker
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.